logo
Select company
Select metric
-26964.86%Free Cash Flow Margin
VS
Market
1
Sector
3
Industry
6
History
-
$ 2.29Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information

Ticker

SABS

Company Name

SAB BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAB BIOTHERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SABS - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -30.93M-26964.86%$ 114.7K
3/31/2025$ -31.55M-8349.39%$ 377.83K
12/31/2024$ -34.63M-2618.65%$ 1.32M
9/30/2024$ -38.56M-2548.8%$ 1.51M
6/30/2024$ -37.37M-1344.3%$ 2.78M
3/31/2024$ -34.52M-1326.6%$ 2.6M
12/31/2023$ -25.27M-1128.73%$ 2.24M
9/30/2023$ -11.66M-284.71%$ 4.09M
6/30/2023$ -14.7M-229.1%$ 6.42M
3/31/2023$ -15.6M-123.02%$ 12.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at -11.8%.
  • Over the past 5 years, SAB BIOTHERAPEUTICS INC's average FCF % has been -3227.32%.
  • The median FCF % for SAB BIOTHERAPEUTICS INC during this period was -706.72%
  • SAB BIOTHERAPEUTICS INC reached its highest FCF % over the past 5 years at -11.8%.
  • The lowest FCF % recorded by SAB BIOTHERAPEUTICS INC in the same timeframe -26964.86%

SAB BIOTHERAPEUTICS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
ABP : ABPRO HOLDINGS INC -4326.23%AIM : AIM IMMUNOTECH INC -9304.13%AIMD : AINOS INC -4465.93%PFSA : PROFUSA INC -1891.88%KAPA : KAIROS PHARMA LTD -PPCB : PROPANC BIOPHARMA INC -QTTB : Q32 BIO INC -CVKD : CADRENAL THERAPEUTICS INC -VIVS : VIVOSIM LABS INC -1007.75%LIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC -

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for SAB BIOTHERAPEUTICS INC is calculated as follows: FCF [ $ -7.19M ] / Revenues [ $ 60.88M ]
(=) FCF % [ -11.8% ]

SABS - Free Cash Flow Margin, Last 5 years

-26964.86%

Minimum

Jun 30, 2025

-11.8%

Maximum

Dec 31, 2021

-3227.32%

Average

-706.72%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.87%
median7.4%
std19.48%